Citius Oncology (CTOR) Anticipates Commercial Launch of LYMPHIR in 2025
Go back to Citius Oncology (CTOR) Anticipates Commercial Launch of LYMPHIR in 2025| (NASDAQ: CTOR) | Delayed: 0.79 +0.04 (5.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.75 | 52 Week High | $ | |||
| Open | $0.74 | 52 Week Low | $ | |||
| Day High | $0.80 | P/E | N/A | |||
| Day Low | $0.73 | EPS | $ | |||
| Volume | 8,455 | |||||
| (NASDAQ: CTXR) | Delayed: 0.58 +0.01 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.57 | 52 Week High | $2.50 | |||
| Open | $0.56 | 52 Week Low | $0.40 | |||
| Day High | $0.59 | P/E | N/A | |||
| Day Low | $0.56 | EPS | $0.00 | |||
| Volume | 199,579 | |||||
